SI
OPTR

Standard Investments’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Standard Investments’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-256,160
Closed -$3.23M – 196
2013
Q3 		$3.23M Buy
+256,160
New +$3.39M 0.61% 20

Standard Investments's OPTR Position: Q4 2013 in Review

Standard Investments sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 256,160 shares — an estimated $3.23M sold.

Standard Investments first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $3.23M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Standard Investments reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Standard Investments sold 256,160 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $3.23M.
  • Standard Investments first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Standard Investments's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $3.23M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Standard Investments's 13F filing for Q4 2013, filed 14 Feb 2014.